Regent Pacific unit Deep Longevity launches Accrua US consumer telehealth platform

Regent Pacific’s Deep Longevity plans to launch Accrua, a US consumer digital health and telehealth platform, in October 2026. Rollout targets all 50 states, extending Deep Longevity’s ageing-clock technology directly to consumers as a new revenue line. Service centers on an AI-generated BloodAge report from routine blood tests, used to guide clinician-led treatment plans. Model uses US telehealth partners, independent physicians, pharmacy and compounding partners; revenue expected to be largely subscription-based. Management cited a comparable US telehealth peer with US$ 400 million revenue in 2025, US$ 1.8 billion run-rate in 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regent Pacific Group Ltd. published the original content used to generate this news brief via (Ref. ID: 202609281126PR_NEWS_USPR_____CN58075) on September 28, 2026, and is solely responsible for the information contained therein. (C) Copyright.